Evaluating breastfeeding in women after cesarean delivery
The Effect Of Post-Birth Analgesia Interventions Performed To Purposed Of Elective Cesarean Delivery With Spinal Anesthesia In Our Hospital On The Initiating Of Breastfeeding And Exclusive Breastfeeding.
This study tests how different pain relief methods after a cesarean delivery affect when and how well mothers start breastfeeding.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | Konya City Hospital Academic / other |
| Locations | 1 site (Konya) |
| Trial ID | NCT06682871 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of analgesia on breastfeeding practices among women who have undergone cesarean deliveries. It focuses on the timing of breastfeeding initiation and the factors influencing mothers' decisions to breastfeed after surgery. The study aims to assess the effectiveness of pain management strategies in promoting early breastfeeding initiation and improving maternal-infant bonding. Participants will be monitored for breastfeeding success and pain levels using established scoring systems.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-45 scheduled for elective cesarean delivery who can provide informed consent and require postoperative pain management.
Not a fit: Patients with hepatic or kidney diseases, known allergies to analgesics, or those on anticoagulants may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance breastfeeding rates and improve health outcomes for both mothers and infants following cesarean deliveries.
How similar studies have performed: Other studies have shown that effective pain management can positively influence breastfeeding outcomes, suggesting this approach may yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent; * 18-45 years old; * ASA Physical Status 1-3; * Scheduled for elective cesarien delivery; * Anticipated hospitalization of at least three nights; * Expected requirement for parenteral opioids for at least 72 hours for postoperative pain; * Able to use IV PCA systems. Exclusion Criteria: * Hepatic disease, e.g. twice the normal levels of liver enzymes; * Kidney disease, e.g. twice the normal level of serum creatinine; * Bupivacaine sensitivity or known allergy; * Anticoagulants considered to be a contraindication for TAP blocks; * Surgeries with high port sites
Where this trial is running
Konya
- Konya City Hospital — Konya, Turkey (Recruiting)
Study contacts
- Principal investigator: Ramazan Keçeci, Specialist — Konya City Hospital
- Study coordinator: Ramazan Keçeci, Specialist
- Email: ramazankececi@yahoo.com
- Phone: 05056162942
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.